Archive for March, 2004

Stock idea – AU Optronics

Sunday, March 28th, 2004 is the Yahoo! finance quote of an interesting stock. According to this data the PEG ratio is .12! You wouldn’t expect such a nice number from a tech stock, but AU Optronics makes LCD panels. I haven’t done any research on this yet, but I’m guessing that the percentage of computers being shipped with LCD screens is on the rise. Throw in a .77% dividend and this has the appearance of a very interesting stock. I’m going to go do some more research…

stocks and stability

Tuesday, March 23rd, 2004

I’ve mentioned CEF in previous entries, but with recent events (killings in the Middle East, terrorism in Spain, political turmoil in Taiwan) it’s more important then ever to diversify in order to protect yourself from volatility. CEF is an investment in silver and gold. Yesterday it was one of the few stocks that went up. That doesn’t mean you should buy it, just that you might want to look at it:

Stock idea – Pfizer

Saturday, March 20th, 2004

Phizer or PFE took over a 2% hit Friday, bringing its forward P/E to just over 14 and it’s dividend yield to almost 2% according to Yahoo Finance (as of March 20th). It might be time to look into Phizer stock, which I’ve owned for a few months now. I should note that I got in at around 34 in January (if memory serves) and it’s 33.95 now. I’m not saying you should buy it, just that you might want to do some research to determine if this recent drop is a buying opportunity.

Stock idea – Lifeline Biotechnologies

Saturday, March 6th, 2004

On November 29, 2003, a friend told me about Lifeline Biotechnologies,, a penny stock which was .0091 cents a share or something. He sold out of it because it has some issues. For one, it keeps issuing new shares to finance its projects, thus diluting shareholder value. He called investor relations, and said that the guy who answered said “Hello” as if it was a home phone line. This made him wary of some sort of scam. However the web site looks quite nice:

One of their products was recently approved by the EU and sales on the Nipplescope (breast cancer detection) begin soon. I got in at around .02 and the stock is now around .027.

Naturally, you have to be extra careful with pinksheet stocks, and honestly I bought this one more on hype (the EU approval and everything) than anything else. As always, I’m not giving advice; just ideas.